Aileron therapeutics inc.

Major-Pharmaceuticals

ALRN


490 Arsenal Way
Watertown , MA 02472

Executive/
Director

Price

  • Last Close
  • $ 2.3
    $ +0.03 1.32 %
    Jan 3, 2025
  • 52-Week High/Low
  • $7.1 - $1.16
  • YTD
  • 0%

  • Trading Volume
  • 2,391
  • Market Cap Full
  • $ 10.4M
  • Shares Outstanding
  • 4.5M
    Oct 11, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 - -22.9% 132.1% -5% 37.5% -9.1% -47.3% 113.2% - -
Q2 3.2% -30.2% -63.9% 4% -12.6% -49.2% 43.2% -50.2% - -
Q3 20% -48.6% 2.3% 8% -18.4% 1492.3% -15.6% 3.6% - -
Q4 -27% -70% -17% -19.4% -44.8% -42.8% 106.8% 8% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 - - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%0%-92%-31%79%-46%321%28%-24%0%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 - -0.52 -0.49 -0.24 -0.08 -1.8 -1.05
Q2 0.45 -0.64 -0.26 -0.14 -0.06 -1.8 -0.39
Q3 0.43 -0.5 -0.28 -0.13 -0.07 -1.4 -0.40
Q4 0.47 -0.48 -0.17 -0.1 -1.69 -1.02 -
A 1.4 -2.1 -1.2 -0.6 -5.9 -6 -1.84

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 14.9 27.8 90.2 90.6 4.5
Jun 14.7 26.7 29.1 90.3 90.8 4.5
Sep 14.7 27.8 39.3 90.6 90.8 4.5
Dec 14.7 27.8 40.7 90.6 90.8 4.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - 0.2
Debt – Equity Ratio - - - - 0.3
Interest Coverage 28 27 - 30 -
Equity multiplier - - - 0.1 0.4